US Stock MarketDetailed Quotes

ARTH ARCH THERAPEUTICS INC

Watchlist
  • 0.300200
  • +0.040200+15.46%
15min DelayClose Oct 18 16:00 ET
1.33MMarket Cap-297P/E (TTM)

ARCH THERAPEUTICS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Total revenue
132.55%30.91K
91.34%31.87K
632.58%45.87K
383.80%75.72K
2,423.44%39.52K
112.31%13.29K
432.08%16.65K
33.33%6.26K
35.34%15.65K
0.06%1.57K
Operating revenue
132.55%30.91K
91.34%31.87K
632.58%45.87K
383.80%75.72K
2,423.44%39.52K
112.31%13.29K
432.08%16.65K
33.33%6.26K
35.34%15.65K
0.06%1.57K
Cost of revenue
13.76%21.08K
15.16%21.56K
33.86%23.61K
51.81%78.16K
18,376.98%23.28K
8.10%18.53K
7.39%18.72K
5.02%17.64K
95.91%51.49K
-99.22%126
Gross profit
287.82%9.83K
599.56%10.31K
295.72%22.26K
93.19%-2.44K
1,027.50%16.24K
51.87%-5.24K
85.57%-2.06K
5.97%-11.37K
-143.51%-35.84K
109.85%1.44K
Operating expense
2.20%1.03M
-37.68%887.05K
19.98%1.52M
-11.12%5.04M
-6.76%1.35M
1.31%1.01M
-18.03%1.42M
-15.58%1.26M
-10.84%5.67M
-15.65%1.44M
Selling and administrative expenses
0.64%875.63K
-45.47%683.18K
18.90%1.31M
-3.29%4.37M
-5.45%1.15M
4.05%870.05K
3.63%1.25M
-12.68%1.1M
-9.78%4.52M
-14.02%1.21M
Research and development costs
11.96%155.68K
19.48%203.87K
27.33%205.58K
-41.83%670.88K
-13.61%199.75K
-13.01%139.05K
-67.66%170.63K
-31.18%161.45K
-14.76%1.15M
-23.27%231.21K
Operating profit
-0.70%-1.02M
38.50%-876.74K
-17.16%-1.49M
11.64%-5.04M
7.79%-1.33M
-0.73%-1.01M
18.58%-1.43M
15.50%-1.28M
10.48%-5.71M
16.45%-1.44M
Net non-operating interest income expense
-472.87%-4.63M
6.74%-592.4K
-126.39%-1.19M
-446.08%-3.1M
-152.20%-1.13M
-1,927.50%-808.77K
-1,510.03%-635.19K
-1,200.09%-524.31K
-276.70%-567.05K
-1,009.32%-447.38K
Non-operating interest expense
-16.92%671.93K
-6.74%592.4K
126.39%1.19M
446.08%3.1M
152.20%1.13M
1,927.50%808.77K
1,510.03%635.19K
1,200.09%524.31K
276.70%567.05K
1,009.32%447.38K
Total other finance cost
--3.96M
----
----
----
----
----
----
----
----
----
Other net income (expense)
15.82%1.16M
0
15.82%1.16M
248.22%1M
0
Gain on sale of security
----
----
----
15.82%1.16M
--0
----
15.82%1.16M
----
817.90%1M
--0
Income before tax
-210.17%-5.65M
-62.79%-1.47M
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
Income tax
Net income
-210.17%-5.65M
-62.79%-1.47M
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
Net income continuous Operations
-210.17%-5.65M
-62.79%-1.47M
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
Minority interest income
Net income attributable to the parent company
-210.17%-5.65M
-62.79%-1.47M
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-210.17%-5.65M
-62.79%-1.47M
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
Basic earnings per share
-1.41%-1.44
53.52%-0.33
60.42%-0.57
48.41%-2.27
65.98%-0.524
-61.36%-1.42
-5.97%-0.71
-9.92%-1.44
26.67%-4.4
23.00%-1.54
Diluted earnings per share
-1.41%-1.44
53.52%-0.33
60.42%-0.57
48.41%-2.27
65.98%-0.524
-61.36%-1.42
-5.97%-0.71
-9.92%-1.44
26.67%-4.4
23.00%-1.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Total revenue 132.55%30.91K91.34%31.87K632.58%45.87K383.80%75.72K2,423.44%39.52K112.31%13.29K432.08%16.65K33.33%6.26K35.34%15.65K0.06%1.57K
Operating revenue 132.55%30.91K91.34%31.87K632.58%45.87K383.80%75.72K2,423.44%39.52K112.31%13.29K432.08%16.65K33.33%6.26K35.34%15.65K0.06%1.57K
Cost of revenue 13.76%21.08K15.16%21.56K33.86%23.61K51.81%78.16K18,376.98%23.28K8.10%18.53K7.39%18.72K5.02%17.64K95.91%51.49K-99.22%126
Gross profit 287.82%9.83K599.56%10.31K295.72%22.26K93.19%-2.44K1,027.50%16.24K51.87%-5.24K85.57%-2.06K5.97%-11.37K-143.51%-35.84K109.85%1.44K
Operating expense 2.20%1.03M-37.68%887.05K19.98%1.52M-11.12%5.04M-6.76%1.35M1.31%1.01M-18.03%1.42M-15.58%1.26M-10.84%5.67M-15.65%1.44M
Selling and administrative expenses 0.64%875.63K-45.47%683.18K18.90%1.31M-3.29%4.37M-5.45%1.15M4.05%870.05K3.63%1.25M-12.68%1.1M-9.78%4.52M-14.02%1.21M
Research and development costs 11.96%155.68K19.48%203.87K27.33%205.58K-41.83%670.88K-13.61%199.75K-13.01%139.05K-67.66%170.63K-31.18%161.45K-14.76%1.15M-23.27%231.21K
Operating profit -0.70%-1.02M38.50%-876.74K-17.16%-1.49M11.64%-5.04M7.79%-1.33M-0.73%-1.01M18.58%-1.43M15.50%-1.28M10.48%-5.71M16.45%-1.44M
Net non-operating interest income expense -472.87%-4.63M6.74%-592.4K-126.39%-1.19M-446.08%-3.1M-152.20%-1.13M-1,927.50%-808.77K-1,510.03%-635.19K-1,200.09%-524.31K-276.70%-567.05K-1,009.32%-447.38K
Non-operating interest expense -16.92%671.93K-6.74%592.4K126.39%1.19M446.08%3.1M152.20%1.13M1,927.50%808.77K1,510.03%635.19K1,200.09%524.31K276.70%567.05K1,009.32%447.38K
Total other finance cost --3.96M------------------------------------
Other net income (expense) 15.82%1.16M015.82%1.16M248.22%1M0
Gain on sale of security ------------15.82%1.16M--0----15.82%1.16M----817.90%1M--0
Income before tax -210.17%-5.65M-62.79%-1.47M-48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M
Income tax
Net income -210.17%-5.65M-62.79%-1.47M-48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M
Net income continuous Operations -210.17%-5.65M-62.79%-1.47M-48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M
Minority interest income
Net income attributable to the parent company -210.17%-5.65M-62.79%-1.47M-48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -210.17%-5.65M-62.79%-1.47M-48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M
Basic earnings per share -1.41%-1.4453.52%-0.3360.42%-0.5748.41%-2.2765.98%-0.524-61.36%-1.42-5.97%-0.71-9.92%-1.4426.67%-4.423.00%-1.54
Diluted earnings per share -1.41%-1.4453.52%-0.3360.42%-0.5748.41%-2.2765.98%-0.524-61.36%-1.42-5.97%-0.71-9.92%-1.4426.67%-4.423.00%-1.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.08%